Pyramid 2 + Type II BVD (Canada)
This treatment applies to the following species:Bovine Rhinotracheitis-Virus Diarrhea Vaccine
Modified Live Virus
BEEF & DAIRY CATTLE
Pyramid 2 + Type II BVD Indications
This product has been shown to be effective for the vaccination of healthy cattle, including pregnant cows, against infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea types 1 and 2 (BVD1 & BVD2). This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.
This product has also been shown to be effective against persistent BVD1 and BVD2 infection of the fetal calf when it is used subcutaneously in the cow or heifer 30 to 60 days pre-breeding. This vaccine may be used in pregnant cows or calves nursing pregnant cows provided the cows were vaccinated pre-breeding, according to label instructions, with any Express® FP vaccine, Pyramid® FP 5, Pyramid® FP 10, Pyramid® 2 + Type II BVD, or Pyramid® FP 5 + Presponse® SQ.
Composition
Contains IBR, BVD1 and BVD2 modified live viruses (MLV) with adjuvant. Gentamicin, neomycin, polymyxin B, and thimerosal added as preservatives.Directions and dosage: Aseptically rehydrate the vaccine with the accompanying diluent. Mix well. Inject one 2 mL dose subcutaneously using aseptic technique.
Protect animals from exposure for at least 14 days after vaccination. Contact your veterinarian or the manufacturer for information on revaccination frequency.
Fetal health risks associated with vaccination of pregnant animals with this vaccine cannot be unequivocally determined by clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian.
Precautions
Store out of direct sunlight at 2-8°C. Do not freeze. Do not mix with other products, except as specified on the label. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. A small percentage of animals may show transient mild injection site swelling. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician. Inactivate unused contents before disposal.For use in animals only.
PYRAMID® and PRESPONSE® are registered trademarks of Boehringer Ingelheim Animal Health USA Inc, used under license.
EXPRESS® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.
Manufactured by:
Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506
Tel.: 1 (888) 637-4251
VLN/PCN 124/1151.26
Distributed by:
Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4
50 Doses/Rehydrate to 100 mL |
This package contains one 50 dose vial of MLV vaccine and one 100 mL vial of diluent. |
158206-02 |
CPN: 1182230.0
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.: | 1-800-567-1885 | |
Technical Services No.: | 1-877-565-5501 | |
Website: | www.boehringer-ingelheim.ca |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details. |
Copyright © 2024 Animalytix LLC. Updated: 2024-11-27